Measurement of Activated Factor VII Using Soluble Mutant Tissue Factor -Proposal for Standardization

Please copy the URL and add it into your RSS Feed Reader.

Facebook Linkedin Weibo

Thromb Haemost 1994; 72(04): 649-650
DOI: 10.1055/s-0038-1648934

Letter to the Editor

Schattauer GmbH Stuttgart

Anthony R Hubbard

Division of Haematology, National Institute for Biological Standards and Control, Potters Bar, Herts., UK

,

Trevor W Barrowcliffe

Division of Haematology, National Institute for Biological Standards and Control, Potters Bar, Herts., UK

Further Information

Publication History

Received 16 May 1994

Accepted after revision 14 June 1994

Publication Date:
06 July 2018 (online)

References
1 Morrissey JH, Macik BG, Neuenschwander PF, Comp PC. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 1993; 81: 734-744

MissingFormLabel
PubMed Search in Google Scholar
2 Hubbard AR, Parr LJ. Potency estimation of activated factor VII concentrates. Thromb Haemost 1991; 65: 1160

MissingFormLabel
PubMed Search in Google Scholar
3 Kitchen S, Malia RG, Preston FE. A comparison of methods for the measurement of activated factor VII. Thromb Haemost 1992; 68: 301-395

MissingFormLabel
Thieme Connect PubMed Search in Google Scholar
4 Hedner U, Ljundberg J, Lund-Hansen T. Comparison of the effect of plasma-derived and recombinant human FVIIa in vitro and in a rabbit model. Blood Coag Fibrinol 1990; 1: 145-152

MissingFormLabel
PubMed Search in Google Scholar
5 WHO Expert Committee on Biological Standardization. Forty-third report. WHO Technical Report Series, No 840 1994

MissingFormLabel
PubMed Search in Google Scholar